Dr. Dave Miller currently serves as the Chief Scientific Officer at AustinPx, where he leads the pharmaceutics, and analytical development teams and oversees the application of the KinetiSol™ Technology. Dr. Miller specializes in formulation and processing technologies for improving oral bioavailability of insoluble small molecules. He has applied his expertise toward advancing numerous drug candidates through all stages of development from early discovery to line extensions. Dr. Miller is the co-inventor of the pharmaceutical applications of KinetiSol Technology and continues to be a key innovative driver for the application and expansion of the platform. Dr. Miller earned his PhD in Pharmaceutics from the University of Texas at Austin.